STOCK TITAN

MDA SEC Filings

MDALF OTC Link

Welcome to our dedicated page for MDA SEC filings (Ticker: MDALF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MDA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MDA's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

MDA Space Ltd. completed a marketed public offering of 9,836,065 common shares at an offering price of US$30.50 per share, generating aggregate gross proceeds of approximately US$300 million. This transaction represents the company’s initial public offering in the United States.

The common shares are listed on the New York Stock Exchange under the symbol “MDA” and continue to trade on the Toronto Stock Exchange under the same symbol. The offering was led by J.P. Morgan and RBC Capital Markets, with a large syndicate of global banks, and includes a 30‑day over-allotment option for up to 1,475,409 additional shares.

MDA Space plans to use the net proceeds to pursue growth strategies, expand its customer base and solutions, support existing customers, and explore strategic opportunities such as acquisitions or investments, while also retaining flexibility to allocate a portion to general corporate purposes, including partial repayment of existing credit facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

MDA Space Ltd. has completed its initial public offering in the United States and listed its common shares on the New York Stock Exchange. The company issued and sold 9,836,065 common shares at US$30.50 per share, raising gross proceeds of approximately US$300 million.

MDA Space plans to use the net proceeds to pursue growth strategies, including expanding its customer base and solutions, supporting existing customers, and pursuing strategic opportunities such as acquisitions or investments. A portion may also be used for general corporate purposes, including repaying amounts under existing credit facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

MDA Space Ltd. has entered an underwriting agreement to issue and sell 9,836,065 common shares to a syndicate led by J.P. Morgan Securities LLC and RBC Dominion Securities Inc. at a purchase price of $30.50 per share.

The company has also granted the underwriters a 30‑day over‑allotment option to buy up to 1,475,409 additional common shares on the same terms. The closing of the base offering is scheduled for March 16, 2026, with the shares expected to be listed on both the NYSE and TSX, subject to customary conditions.

As of March 10, 2026, MDA Space had 126,563,893 common shares outstanding, so this equity offering represents a meaningful new share issuance that will provide additional capital while diluting existing holders to some extent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

MDA Space Ltd. files a cross‑border offering to sell US$300,000,000 of Common Shares. The Prospectus Supplement to the Company’s short form base shelf prospectus qualifies an initial public offering in the United States and a new issue in Canada of Common Shares, with an Over‑Allotment Option equal to 15% of the Offered Shares.

The Offered Shares will be listed on the TSX and the NYSE under the trading symbol “MDA” pending satisfaction of listing requirements. As at the date of the Prospectus Supplement, 126,563,893 Common Shares are issued and outstanding. Proceeds are to be used for growth strategies, potential acquisitions, general corporate purposes and may include repayment of amounts under the Company’s Syndicated Credit Facility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration

FAQ

How many MDA (MDALF) SEC filings are available on StockTitan?

StockTitan tracks 6 SEC filings for MDA (MDALF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for MDA (MDALF)?

The most recent SEC filing for MDA (MDALF) was filed on March 31, 2026.

MDALF Rankings

MDALF Stock Data

4.26B
122.13M
Aerospace & Defense
Industrials
Link
Canada
Brampton

MDALF RSS Feed